UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000040886
Receipt No. R000046482
Scientific Title Most Preventable surgical option to reduce primary spontaneous pneumothorax patients postoperative recurrence: A prospective cohort study
Date of disclosure of the study information 2020/07/01
Last modified on 2020/06/24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Most Preventable surgical option to reduce primary spontaneous pneumothorax patients postoperative recurrence: A prospective cohort study
Acronym PATCH Study
Scientific Title Most Preventable surgical option to reduce primary spontaneous pneumothorax patients postoperative recurrence: A prospective cohort study
Scientific Title:Acronym PATCH Study
Region
Japan

Condition
Condition Primary spontaneous pneumothorax
Classification by specialty
Chest surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To investigate the most preventable option to reduce primary spontaneous postoperative recurrence.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Rate of ipsilateral pneumothorax recurrence detected by radiography at two years after surgery
Key secondary outcomes Complication rates, surgical duration, blood loss, reoperation rate for recurrent pneumothorax

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
16 years-old <=
Age-upper limit
40 years-old >
Gender Male and Female
Key inclusion criteria 1)Patients who have spontaneous pneumotho rax diagnosed by radiography and plan to und erwent initial VATS bullectomy.
2)Patients who receive informed consent to at tend this study, and the agreements are provi ded in a document.
The consent of parents are also required, in ca se patients are under 20-years old.
Key exclusion criteria 1)History of ipsilateral chest surgery.
2)Patients who only underwent exploratory surgery.
3)Patients who are judged ineligible by the in vestigator and the attending surgeon.
Target sample size 450

Research contact person
Name of lead principal investigator
1st name Chen
Middle name
Last name Yoshikawa
Organization Nagoya University Graduate School of Medicin e
Division name Department of Thoracic Surgery
Zip code 466-8560
Address 65 Tsurumai-cho, Showa-ku, Nagoya 466-855 0, Japan
TEL 052-744-2375
Email tyoshikawa@med.nagoya-u.ac.jp

Public contact
Name of contact person
1st name Yuka
Middle name
Last name Kadomatsu
Organization Nagoya University Graduate School of Medicin e
Division name Department of Thoracic Surgery
Zip code 466-8560
Address 65 Tsurumai-cho, Showa-ku, Nagoya 466-855 0, Japan
TEL 052-744-2375
Homepage URL
Email ykadomatsu@med.nagoya-u.ac.jp

Sponsor
Institute Department of Thoracic Surgery, Nagoya Univ ersity Graduate School of Medicine, Nagoya, J apan
Institute
Department

Funding Source
Organization Department of Thoracic Surgery, Nagoya Univ ersity Graduate School of Medicine, Nagoya, J apan
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Nagoya University Hospital Institutional review board
Address 65 Tsurumai-cho, Showa-ku, Nagoya 466-855 0, Japan
Tel 052-744-1958
Email center@med.nagoya-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 名古屋大学病院(愛知県)

Other administrative information
Date of disclosure of the study information
2020 Year 07 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Preinitiation
Date of protocol fixation
2020 Year 06 Month 24 Day
Date of IRB
Anticipated trial start date
2020 Year 08 Month 01 Day
Last follow-up date
2026 Year 12 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information The study protocol is going to be approved at each institution.

Management information
Registered date
2020 Year 06 Month 24 Day
Last modified on
2020 Year 06 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046482

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.